Delivery Order SPE2DB24D2011-SPE2DB24FBQMF
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$7.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of 4565043701 DORZOLAMIDE HCL 2% EYE DROPS 10ML to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $1,390.32, has a period of performance through July 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC...
The Defense Logistics Agency (DLA) awarded a $1,046.40 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,415,169 units of Dorzolamide HCl 2% eye drops in 10 mL bottles. The order has an ultimate completion date of August 12, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract, valued at up to $3,744.00, is for the delivery of 4565900457 DORZOLAMIDE HCL 2% EYE DROPS 10ML. This is a Firm Fixed Price Delivery Order contract with a completion date of September 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medications,...
This federal contract award is for the delivery of Dorzolamide HCL 2% Eye Drops, 10 mL, to the Defense Logistics Agency (DLA). The contract, valued at $4,205.62, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of November 13, 2024. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,011.38 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the supply of 4564053657 - Dorzolamide HCl 2% eye drops (10 ml) to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug...
This federal contract award is for the delivery of Dorzolamide HCL 2% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for a ceiling value of $2,570.95. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 11, 2024. The award was made on January 10, 2024, and there was no set-aside designation used. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Dorzolamide-Timolol eye drops. The $5,035.03 firm fixed-price delivery order has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Dorzolamide HCL 2% eye drops, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,654.30 firm fixed-price delivery order contract has an ultimate completion date of October 23, 2023. The contract is not designated as a set-aside and appears to be part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award, valued at $7,594.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565243277 - DORZOLAMIDE-TIMOLOL EYE DROPS 10ML. This is a Firm Fixed Price Delivery Order contract with a completion date of July 25, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,442.75, is for the delivery of Dorzolamide-Timolol eye drops, a pharmaceutical product used for the treatment of eye conditions. The contract is a delivery order, with a firm-fixed price pricing type and an ultimate completion date of January 29, 2025. Amerisourcebergen holds a significant...